The person responsible for disease control in China, said his country is formally considering mixed use vaccines against COVID-19, as a way to enhance the effectiveness of vaccination.
Available data show that Chinese vaccines lag behind other vaccines, including Pfizer and Moderna, in terms of efficacy, but require less rigorous temperature control during storage.
The vaccines available now “do not have very high levels of protection,” Gao Fu, director of the China Centers for Disease Control and Prevention, told a conference in the Chinese city of Chengdu yesterday.
“Vaccination using vaccines from different technical lines is being considered,” he said.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
